The Weekly Litigation News Digest is now live. Subscribe now

Glenmark Life Sciences competitive analysis

Loading summary...

Explore patent oppositions filed by Glenmark Life Sciences against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Nov 13, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

Amorphous Lercanidipine HydrochlorideRECORDATI INDUSTRIA CHIMICA E FARMACEUTICANov 13, 2019

Explore Glenmark Life Sciences's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Nov 13, 2025
Patent NumberPublication DateTitleTotal Oppositions
Jan 22, 2025Process For Preparation Of Apremilast2

Latest PTAB cases involving Glenmark Life Sciences

Discover the latest PTAB cases involving Glenmark Life Sciences, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Glenmark Life Sciences with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Nov 13, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
GLENMARK LIFE SCIENCES12 - -
HAMM & WITTKOPP112 - - -
RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA - 7 - -
RECORDATI IRELAND - 7 - -